Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemoglobin Beta Thalassemia”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Testing effectiveness (Phase 2)Study completedNCT00005934
What this trial is testing

5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia

Who this might be right for
Beta Thalassemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT07486531
What this trial is testing

Iron Accumulation in Erythrocytes in Patients

Who this might be right for
Beta Thalassemia Major
Ankara City Hospital Bilkent 100
Not applicableStudy completedNCT02326597
What this trial is testing

Decision Aid for Therapeutic Options In Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaHemoglobin SS+2 more
Emory University 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT05353647
What this trial is testing

A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)

Who this might be right for
Sickle Cell Disease
David Williams 25
Early research (Phase 1)Study completedNCT00005783
What this trial is testing

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Who this might be right for
Hemoglobin SC DiseaseSickle Cell Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Large-scale testing (Phase 3)UnknownNCT04191213
What this trial is testing

Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients

Who this might be right for
Sickle Cell Anemia in Children
Al-Neelain University 100
Testing effectiveness (Phase 2)Study completedNCT01745120
What this trial is testing

A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants

Who this might be right for
β-thalassemia Major
Genetix Biotherapeutics Inc. 19
Not applicableActive Not RecruitingNCT05675436
What this trial is testing

Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

Who this might be right for
Sickle Cell AnemiaSickle Cell ThalassemiaSickle Cell Pain+5 more
National Heart, Lung, and Blood Institute (NHLBI) 6
Not applicableEnrolling By InvitationNCT06363760
What this trial is testing

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

Who this might be right for
Sickle Cell DiseaseTransfusion-dependent Beta-ThalassemiaHemoglobinopathies
Editas Medicine, Inc. 54
Not applicableActive Not RecruitingNCT04691323
What this trial is testing

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 68
Not applicableStudy completedNCT04678037
What this trial is testing

Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study

Who this might be right for
Sickle Cell DiseaseSickle Cell Hemoglobin CSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableStudy completedNCT01443312
What this trial is testing

Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia

Who this might be right for
Thalassemia
HaEmek Medical Center, Israel 28
Not applicableStudy completedNCT06831799
What this trial is testing

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseSickle Cell Anemia+21 more
Hospital Universitari Vall d'Hebron Research Institute 684
Testing effectiveness (Phase 2)UnknownNCT02453477
What this trial is testing

Gene Therapy for Transfusion Dependent Beta-thalassemia

Who this might be right for
Beta-Thalassemia
IRCCS San Raffaele 10
Post-approval studies (Phase 4)Study completedNCT06606886
What this trial is testing

Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia

Who this might be right for
Transfusion Dependent Beta-thalassemia
Bahria University 96
Testing effectiveness (Phase 2)Study completedNCT03877809
What this trial is testing

Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients

Who this might be right for
Beta-Thalassemia
Rare Partners srl Impresa Sociale 26
Testing effectiveness (Phase 2)Study completedNCT01609595
What this trial is testing

Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand

Who this might be right for
Beta Thalassemia Intermedia
Boston University 10
Testing effectiveness (Phase 2)Study completedNCT04987489
What this trial is testing

Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseThalassemia
Forma Therapeutics, Inc. 53
Early research (Phase 1)Looking for participantsNCT07431398
What this trial is testing

Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Fulcrum Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT01642758
What this trial is testing

Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon

Who this might be right for
Beta Thalassemia Intermedia
Boston University 10
Load More Results